Radiation dose, driving performance, and cognitive function in patients with head and neck cancer

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 304-307

  Yuen, Hon K ^a   Sharma, Anand K ^b   Logan, William C ^c   Gillespie, M Boyd ^b   Day, Terry A ^b   Brooks, Johnell O ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c University Medical Group   (United States)

^d CLEMSON UNIVERSITY   (United States)

Author keywords

Adverse effects; Cognition disorders; Neuropsychological tests; Traffic accidents

Indexed keywords

CISPLATIN; PACLITAXEL; RITUXIMAB;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRIVING ABILITY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MONOTHERAPY; MOTOR PERFORMANCE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; AUTOMOBILE DRIVING; COGNITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIATION DOSAGE; TEMPORAL LOBE;

EID: 43049156426     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.03.020     Document Type: Article

References (27)

1. Abayomi O.K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 41 (2002) 346-351
2. Cross N.E., and Glantz M.J. Neurologic complications of radiation therapy. Neurol Clin 21 (2003) 249-277
3. Zackrisson B., Mercke C., Strander H., Wennerberg J., and Cavallin-Stahl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 42 (2003) 443-461
4. Filley C.M. Toxic leukoencephalopathy. Clin Neuropharmacol 22 (1999) 249-260
5. Lam L.C., Leung S.F., and Chan Y.L. Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. J Neuropsychiatry Clin Neurosci 15 (2003) 90-97
6. Lee A.W., Foo W., Chappell R., et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40 (1998) 35-42
7. Meyers C.A., Geara F., Wong P.F., and Morrison W.H. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 46 (2000) 51-55
8. Yuen H.K., Gillespie M.B., Barkley R.A., Day T.A., Bandyopadhyay D., and Sharma A.K. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg 133 (2007) 904-909
9. Yuen H.K., Gillespie M.B., Day T.A., Morgan L., and Burik J.K. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck 29 (2007) 675-681
10. Shipley W. The Shipley Institute of living scale (1946), Western Psychological Services, Inc., Los Angeles
11. Reitan R. The validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 8 (1958) 271-276
12. Lezak M.D. Neuropsychological assessment (1983), Oxford University Press, New York
13. Anderson-Hanley C., Sherman M.L., Riggs R., Agocha V.B., and Compas B.E. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9 (2003) 967-982
14. Reitan R. Trail making test manual for administration and scoring. Reitan Neuropsychological Laboratory, Tucson (AZ); 1986.
15. Stutts J.C., Stewart J.R., and Martell C. Cognitive test performance and crash risk in an older driver population. Accid Anal Prev 30 (1998) 337-346
16. Grace J., Amick M.M., D'Abreu A., Festa E.K., Heindel W.C., and Ott B.R. Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease. J Int Neuropsychol Soc 11 (2005) 766-775
17. Tarawneh M., McCoy P., Bishu R., and Ballard J. Factors associated with driving performance of older drivers. Transport Res Rec 1405 (1993) 64-71
18. Szlyk J.P., Myers L., Zhang Y., Wetzel L., and Shapiro R. Development and assessment of a neuropsychological battery to aid in predicting driving performance. J Rehabil Res Dev 39 (2002) 483-496
19. Galski T., Williams J.B., and Ehle H.T. Effects of opioids on driving ability. J Pain Symptom Manage 19 (2000) 200-208
20. Byas-Smith M.G., Chapman S.L., Reed B., and Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 21 (2005) 345-352
21. Vainio A., Ollila J., Matikainen E., Rosenberg P., and Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346 (1995) 667-670
22. Spreen O., and Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary (1991), Oxford University Press, New York
23. Roberts C., and Horton Jr. A.M. Using the Trail Making test to screen for cognitive impairment in a drug abuse treatment sample. Int J Neurosci 109 (2001) 273-280
24. Stokholm J., Vogel A., Gade A., and Waldemar G. The executive interview as a screening test for executive dysfunction in patients with mild dementia. J Am Geriatr Soc 53 (2005) 1577-1581
25. Franzblau A.N. A primer of statistics for non-statisticians (1958), Harcourt, New York
26. Ball K.K., Roenker D.L., Wadley V.G., et al. Can high-risk older drivers be identified through performance-based measures in a Department of Motor Vehicles setting?. J Am Geriatr Soc 54 (2006) 77-84
27. American Medical Association, US Department of Transportation, National Highway Traffic Safety Administration. Physician's guide to assessing and counseling older drivers; 2003.